About MASPHO | Committee | Contact Us | Home
 
14th ASM

 




arrow Management of renal tumours in childhood

Updated: 5-08-2009
Nephroblastoma (Wilms tumour). Metanephrictumours–stromal,adenofibroma,adenoma. Other adenoma. Cystic nephroma. Renal cell carcinoma.
» Read more...


arrow Evaluation of disease extent in childhood cancer

Updated: 5-08-2009
Imaging based on uptake of positron emitting radionuclide by tissue of interest. Nature of uptake dependant on the chemical to which the isotope is bound. Standard oncology imaging uses fluoro deoxy glucose (FDG). Isotopes used include 11C,18F,13N,15O,124I,86Y
» Read more...


arrow Risk Adapted Therapy in Neuroblastoma

Updated: 5-08-2009
To What Extent Can Treatment Be Reduced In Good Risk Patients?.How Can Outcome Be Improved In Poor Risk Patients?.Can Initial Staging Methods Be Improved?
.What Are The Most Useful Prognostic Factors?

» Read more...


arrow Invasive Fungal Infection (IFI) in the setting of haematologgy-oncology

Updated: 5-08-2009
Epidemiology.Risk factors.Therapy.Strategies for managing inv.Prevention.Early intervention
» Read more...


arrow Febrile neutropenia State of the art

Updated: 5-08-2009
Mortality (~9.5%).Dose reduction and delays with chemotherapy. Mean length of stay~11.5 days. Costs ($US19,110 per hospitalisation).
» Read more...

 

© Copyright Malaysian Society of Paediatric Haematology and Oncology 2007 - 2010     All rights reserved.